TY - JOUR
T1 - Exploration of Pyrazolo[1,5-a]pyrimidines as Membrane-Bound Pyrophosphatase Inhibitors
AU - Johansson, Niklas G
AU - Dreano, Loic
AU - Vidilaseris, Keni
AU - Khattab, Ayman
AU - Liu, Jianing
AU - Lasbleiz, Arthur
AU - de Castro Ribeiro, Orquidea Marilia
AU - Kiriazis, Alexandros
AU - Boije af Gennäs, Gustav
AU - Meri, Seppo
AU - Goldman, Adrian
AU - Yli-Kauhaluoma, Jari
AU - Xhaard, Henri
PY - 2021/11/5
Y1 - 2021/11/5
N2 - Inhibition of membrane-bound pyrophosphatase (mPPase) with small molecules offer a new approach in the fight against pathogenic protozoan parasites. mPPases are absent in humans, but essential for many protists as they couple pyrophosphate hydrolysis to the active transport of protons or sodium ions across acidocalcisomal membranes. So far, only few nonphosphorus inhibitors have been reported. Here, we explore the chemical space around previous hits using a combination of screening and synthetic medicinal chemistry, identifying compounds with low micromolar inhibitory activities in the Thermotoga maritima mPPase test system. We furthermore provide early structure-activity relationships around a new scaffold having a pyrazolo[1,5-a]pyrimidine core. The most promising pyrazolo[1,5-a]pyrimidine congener was further investigated and found to inhibit Plasmodium falciparum mPPase in membranes as well as the growth of P. falciparum in an ex vivo survival assay.
AB - Inhibition of membrane-bound pyrophosphatase (mPPase) with small molecules offer a new approach in the fight against pathogenic protozoan parasites. mPPases are absent in humans, but essential for many protists as they couple pyrophosphate hydrolysis to the active transport of protons or sodium ions across acidocalcisomal membranes. So far, only few nonphosphorus inhibitors have been reported. Here, we explore the chemical space around previous hits using a combination of screening and synthetic medicinal chemistry, identifying compounds with low micromolar inhibitory activities in the Thermotoga maritima mPPase test system. We furthermore provide early structure-activity relationships around a new scaffold having a pyrazolo[1,5-a]pyrimidine core. The most promising pyrazolo[1,5-a]pyrimidine congener was further investigated and found to inhibit Plasmodium falciparum mPPase in membranes as well as the growth of P. falciparum in an ex vivo survival assay.
KW - 5-a]pyrimidine
KW - ACIDOCALCISOMES
KW - ANTIMALARIAL
KW - H+-PPASE
KW - INORGANIC PYROPHOSPHATASE
KW - LOCALIZATION
KW - PLASMODIUM-FALCIPARUM
KW - TARGET
KW - antiprotozoal agents
KW - drug discovery
KW - inhibitor
KW - membrane-bound pyrophosphatase
KW - pyrazolo[1
KW - 317 Pharmacy
U2 - 10.1002/cmdc.202100392
DO - 10.1002/cmdc.202100392
M3 - Article
VL - 16
SP - 3360
EP - 3367
JO - ChemMedChem : chemistry enabling drug discovery.
JF - ChemMedChem : chemistry enabling drug discovery.
SN - 1860-7179
IS - 21
ER -